The ability of IL-17A to protect against development of autoimmune uveitis and ulcerative colitis [49], [50] has been demonstrated; however, this contrasts with the reported disease-promoting role of Th17 cells in MS [51]–[53], and will need further clarification. Here, IL17A is linked to myeloid sarcoma.